Researchers from the University of Pittsburgh have developed a new way to grow T cells in the lab that enables them to live longer and better destroy cancer cells in a mouse model of melanoma compared ...

Researchers identify glucose usage as one major divergence betweenT cells expanding in vitro versus those expanding in vivo.

Researchers have revolutionized cancer immunotherapy by developing a way to grow T cells in the lab that live longer and ...

If you're looking for an under-the-radar stock that could deliver enormous gains in a defined time frame, the ...

Retired Ballyconnell GP Dr Susan Cosnett is set to return home to Cavan this week after receiving cancer treatment in Holland ...

Research led by the Chiba Cancer Center Research Institute in Japan has discovered a surprising way cancer evades the immune ...

A Bay Area biotech is suing its insurance company to cover costs associated with patients allegedly injured during clinical ...

Lisata Therapeutics (LSTA) and WARPNINE announced encouraging preliminary results from the Phase 1b/2a iLSTA trial evaluating certepetide, ...

After a Stage 4 cancer diagnosis and a prognosis of 16 months to live, Katie Doble didn’t know whether she should plan her ...

Research has introduced daromun, therapeutic vaccines, and novel combinations for metastatic melanoma, reshaping the ...